Full Professor(heuristic)

Cancer Immunotherapy and Biomarkers · Oncology

h-index75
i10-index296
Publications1,067
Citations23,924

Grants

5 total · 3 active

NIH #5R01CA279749-03

Integrating patient-reported outcomes and T-cell receptor sequencing to predict immune-related adverse events

Active
Amount
$636K
Period
2024-01-19 → 2028-12-31
PIs
1
Est. capacity / PI
~5 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #5R01CA279749-02

Integrating patient-reported outcomes and T-cell receptor sequencing to predict immune-related adverse events

Active
Amount
$657K
Period
2024-01-19 → 2028-12-31
PIs
1
Est. capacity / PI
~5 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #1R01CA279749-01A1

Integrating patient-reported outcomes and T-cell receptor sequencing to predict immune-related adverse events

Active
Amount
$657K
Period
2024-01-19 → 2028-12-31
PIs
1
Est. capacity / PI
~5 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.

All Grants

5 total · 3 active

NIH #5R01CA279749-03

Integrating patient-reported outcomes and T-cell receptor sequencing to predict immune-related adverse events

Active
Amount
$636K
Period
2024-01-19 → 2028-12-31
PIs
1
Est. capacity / PI
~5 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #5R01CA279749-02

Integrating patient-reported outcomes and T-cell receptor sequencing to predict immune-related adverse events

Active
Amount
$657K
Period
2024-01-19 → 2028-12-31
PIs
1
Est. capacity / PI
~5 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #1R01CA279749-01A1

Integrating patient-reported outcomes and T-cell receptor sequencing to predict immune-related adverse events

Active
Amount
$657K
Period
2024-01-19 → 2028-12-31
PIs
1
Est. capacity / PI
~5 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #5R21CA137633-02

Phase I Study of IMC-A12 in Combination with Temsirolimus

Amount
$332K
Period
2009-06-15 → 2012-05-31
PIs
1
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #1R21CA137633-01A1

Phase I Study of IMC-A12 in Combination with Temsirolimus

Amount
$332K
Period
2009-06-15 → 2011-05-31
PIs
1
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

Potential Collaborators

Recent Publications

Last 2 years · showing 20 of 107
Open author page on OpenAlex →